About
Melinta Therapeutics is a biopharmaceutical company focused on developing innovative therapies for acute and life-threatening infections. Recently, it was acquired by CorMedix for $300 million, enhancing CorMedix's portfolio in the biopharmaceutical sector.
Focus
Office
Lease
Markets
Headquarters
Parsippany, New Jersey, United States
FAQs
Melinta Therapeutics has financed 1 deal.
Member since: October 2024
Deals
Transaction Type
Asset Type
State
Sort By
LEASED
Melinta Therapeutics Leases 8876 Square Feet At 100 Tri State International Lincolnshire
100 Tri State International, Lincolnshir..., Lincolnshire, IL
ILCRE
Nov 19, 2023